Eam Global Investors LLC Castle Biosciences Inc Transaction History

Eam Global Investors LLC

  • $402 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$58.92 - $97.33 $2.19 Million - $3.61 Million
-37,141 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$43.6 - $73.05 $843,006 - $1.41 Million
-19,335 Reduced 34.24%
37,141 $2.49 Million
Q1 2020

May 13, 2020
BUY
$23.08 - $35.53 $164,306 - $252,938
7,119 Added 14.42%
56,476 $1.68 Million
Q4 2019

Feb 10, 2020
BUY
$15.74 - $35.04 $84,728 - $188,620
5,383 Added 12.24%
49,357 $1.7 Million
Q3 2019

Nov 13, 2019
BUY
$18.09 - $27.92 $795,489 - $1.23 Million
43,974 New
43,974 $795,000

Others Institutions Holding CSTL

# of Institutions
171
Shares Held
25.5M
Call Options Held
511K
Put Options Held
130K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $750M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email